Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
10 participants
INTERVENTIONAL
2013-08-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methods Project 4: Clinical Trial - Amended
NCT03111537
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
NCT02342795
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
NCT00894166
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
e-Cigarette
STAM 1100mAh CE4 eGo Clearomizer e-Cigarette
STAM 1100mAh CE4 eGo Clearomizer
Nicotine polacrilex
Nicotine Replacement gum
Nicotine polacrilex
2 mg and 4 mg gum will be used according to the FDA approved product labelling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine polacrilex
2 mg and 4 mg gum will be used according to the FDA approved product labelling
STAM 1100mAh CE4 eGo Clearomizer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No current or previous regular use of e-cigarettes
* Ready to quit smoking
Exclusion Criteria
* Smoke more than 40 cigarettes per day
* Pregnant or breastfeeding
* Unable to chew gum due to dental or jaw problems
* Myocardial infarction (heart attack) within the previous 12 months
* Hypersensitivity to propylene glycol or nicotine gum
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Creighton University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy J Arouni, MD
Role: PRINCIPAL_INVESTIGATOR
Creighton University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Creighton University
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-16684
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.